Selectivity for cox cyclooxygenase aspirin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Blood Platelets Cells, Cultured Seminal Vesicles Gastric Mucosa Endothelium, Vascular Cell Line Visual Cortex Microsomes Neurons Macrophages Muscle, Smooth, Vascular Cell Line, Tumor Kidney Intestinal Mucosa Arterioles Tumor Cells, Cultured Mesenteric Arteries

Organisms8

Rats, Sprague-Dawley Rats, Wistar Rabbits Sheep Dogs Mice, Inbred C57BL Guinea Pigs Mice, Knockout

Diseases14

Asthma, Aspirin-Induced Stomach Ulcer Hemorrhage Gastrointestinal Hemorrhage Thrombosis Myocardial Infarction Inflammation Gastrointestinal Diseases Disease Models, Animal Cardiovascular Diseases Colonic Neoplasms Stroke Colorectal Neoplasms Reye Syndrome

Chemicals and Drugs130

Aspirin Cyclooxygenase 2 Cyclooxygenase 1 Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Prostaglandin-Endoperoxide Synthases Anti-Inflammatory Agents, Non-Steroidal Dinoprostone Indomethacin Prostaglandins Thromboxane B2 Isoenzymes Platelet Aggregation Inhibitors Arachidonic Acid Ibuprofen Sulfonamides Nitrobenzenes Pyrazoles Lipoxygenase Inhibitors Membrane Proteins Arachidonic Acids 6-Ketoprostaglandin F1 alpha Salicylates Epoprostenol Thromboxane A2 Lipoxygenase Flurbiprofen Thromboxanes Eicosanoids Naproxen Ticlopidine Diclofenac Masoprocol Thromboxane-A Synthase Piroxicam Sodium Salicylate Intramolecular Oxidoreductases Hydroxyeicosatetraenoic Acids Arachidonate 5-Lipoxygenase Receptors, Prostaglandin E Thiazines Sulfones Prostaglandins E Enzyme Inhibitors Dinoprost Meclofenamic Acid Lactones Nitric Oxide Prostaglandins G 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine 5,8,11,14-Eicosatetraynoic Acid Lipoxins Nitric Oxide Synthase RNA, Messenger Sulindac Phospholipases A Fibrinolytic Agents Acetaminophen Leukotrienes Phospholipases A2 Prostaglandin Antagonists Receptors, Thromboxane Ketorolac Bradykinin Prostaglandin D2 Prostaglandin H2 8,11,14-Eicosatrienoic Acid Leukotriene B4 Anticoagulants Arachidonate Lipoxygenases Warfarin Hydrazines Calcimycin Ligands Tablets, Enteric-Coated Receptors, Prostaglandin Tolmetin Receptors, Prostaglandin E, EP4 Subtype Anti-Inflammatory Agents Ketoprofen Receptors, Prostaglandin E, EP1 Subtype Lipopolysaccharides Prostaglandins H Interleukin-1 Nitric Oxide Synthase Type II 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid Sulfinpyrazone Vasodilator Agents Acetylcholine 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid NG-Nitroarginine Methyl Ester Receptors, Prostaglandin E, EP2 Subtype Electron Transport Complex IV Prostaglandins F Calcium Receptors, Thromboxane A2, Prostaglandin H2 Pyridines Peroxidases Recombinant Proteins Dipyridamole Vasoconstrictor Agents Cations SRS-A Anticarcinogenic Agents Salicylic Acid Thiazoles Receptors, Prostaglandin E, EP3 Subtype Isoxazoles Nitroarginine Imidazoles Potassium Channels NF-kappa B Furans Ketorolac Tromethamine Biological Factors Analgesics, Non-Narcotic Nitric Oxide Donors Cytochrome P-450 Enzyme System Cyclic AMP Anions Ions Quinacrine Fatty Acids, Unsaturated Potassium Peptides Sodium Phospholipases A2, Cytosolic Adenosine Diphosphate Tumor Necrosis Factor-alpha beta-Thromboglobulin

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Platelet Function Tests Drug Therapy, Combination Models, Molecular Proportional Hazards Models Risk Factors Bleeding Time Prospective Studies Double-Blind Method Treatment Outcome Blotting, Western Chromatography, High Pressure Liquid Follow-Up Studies Cohort Studies Immunohistochemistry Mutagenesis, Site-Directed Reverse Transcriptase Polymerase Chain Reaction Prognosis Disease Models, Animal Radioligand Assay Drug Design Crystallography, X-Ray Risk Assessment Inhibitory Concentration 50 Photic Stimulation Models, Biological Binding, Competitive Chemoprevention Blood Pressure Incidence Transfection Models, Chemical Analysis of Variance Retrospective Studies Drug Administration Schedule Administration, Oral

Psychiatry and Psychology1

Phenomena and Processes36

Platelet Aggregation Dose-Response Relationship, Drug Time Factors Structure-Activity Relationship Kinetics Substrate Specificity Molecular Structure Vasodilation Binding Sites Amino Acid Sequence Gene Expression Regulation, Enzymologic Enzyme Induction Stereoisomerism Platelet Activation Drug Interactions Bleeding Time Vasoconstriction Protein Binding Signal Transduction Drug Resistance Protein Conformation Ion Channel Gating Drug Synergism Inhibitory Concentration 50 Base Sequence Protein Structure, Tertiary Binding, Competitive Membrane Potentials Mutation Enzyme Activation Catalysis Apoptosis Up-Regulation Blood Pressure Cell Membrane Permeability Transfection

Disciplines and Occupations3

Immunohistochemistry Drug Design Electrophysiology

Information Science4

Molecular Sequence Data Amino Acid Sequence Base Sequence Incidence

Health Care11

Proportional Hazards Models Risk Factors Prospective Studies Double-Blind Method Treatment Outcome Follow-Up Studies Cohort Studies Risk Assessment Incidence Analysis of Variance Retrospective Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Health Care

Aspirin Cyclooxygenase 2 Cyclooxygenase 1 Cyclooxygenase Inhibitors Cyclooxygenase 2 Inhibitors Prostaglandin-Endoperoxide Synthases Anti-Inflammatory Agents, Non-Steroidal Dinoprostone Indomethacin Prostaglandins Thromboxane B2 Isoenzymes Platelet Aggregation Inhibitors Arachidonic Acid Ibuprofen Sulfonamides Nitrobenzenes Pyrazoles Lipoxygenase Inhibitors Membrane Proteins Arachidonic Acids 6-Ketoprostaglandin F1 alpha Salicylates Platelet Aggregation Epoprostenol Dose-Response Relationship, Drug Thromboxane A2 Lipoxygenase Flurbiprofen Thromboxanes Eicosanoids Naproxen Blood Platelets Ticlopidine Diclofenac Masoprocol Thromboxane-A Synthase Piroxicam Time Factors Platelet Function Tests Sodium Salicylate Intramolecular Oxidoreductases Hydroxyeicosatetraenoic Acids Arachidonate 5-Lipoxygenase Receptors, Prostaglandin E Thiazines Sulfones Prostaglandins E Enzyme Inhibitors Dinoprost Cells, Cultured Meclofenamic Acid Lactones Structure-Activity Relationship Drug Therapy, Combination Kinetics Nitric Oxide Prostaglandins G Models, Molecular Seminal Vesicles Rats, Sprague-Dawley Molecular Sequence Data Proportional Hazards Models Asthma, Aspirin-Induced Substrate Specificity 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine 5,8,11,14-Eicosatetraynoic Acid Gastric Mucosa Molecular Structure Vasodilation Lipoxins Nitric Oxide Synthase RNA, Messenger Risk Factors Binding Sites Amino Acid Sequence Stomach Ulcer Endothelium, Vascular Gene Expression Regulation, Enzymologic Sulindac Phospholipases A Fibrinolytic Agents Acetaminophen Leukotrienes Phospholipases A2 Enzyme Induction Prostaglandin Antagonists Stereoisomerism Receptors, Thromboxane Rats, Wistar Platelet Activation Ketorolac Drug Interactions Cell Line Bradykinin Bleeding Time Prostaglandin D2 Hemorrhage Vasoconstriction Prospective Studies

No FAQ available that match "selectivity for cox cyclooxygenase aspirin"